MeSH D012771 - hemorrhagic shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Mylan | Polyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate | Colyte With Flavor Packs |  | 1984-10-26 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
63%5/8
Phase 3
11%1/9
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use